Prognostic value of glycated hemoglobin in colorectal cancer

Table 2 Glycemic parameters in colorectal cancer patients and non-cancer controls

	CRC	Controls	P value
Overall population	n = 224	n = 112
Fasting blood glucose	106 ± 35	101 ± 39
(mg/dL)	(65-415)	(61-289)	0.219
Fasting insulin (μIU/mL)	14.2 (8.7-23.3)	9.0 (6.0-12.2)	< 0.0001
HbA1c (%)	5.98 ± 0.83	5.63 ± 1.10
	(4.30-13.0)	(3.90-9.70)	0.001
HOMA index	3.5 (2.0-6.1)	2.0 (1.3-3.3)	< 0.0001
Non-diabetic	n = 173	n = 87
Fasting blood glucose	100 ± 25	87 ± 12
(mg/dL)	(65-254)	(61-123)	< 0.0001
Fasting insulin (μIU/mL)	12.5 (8.5-18.6)	7.6 (5.1-10.9)	< 0.0001
HbA1c (%)	5.72 ± 0.36	5.14 ± 0.42
	(4.30-7.10)	(3.90-6.10)	< 0.0001
HOMA index	2.8 (1.8 -4.8)	1.7 (1.0-2.5)	< 0.0001
Non-diabetic normoweight	n = 90	n = 51
Fasting blood glucose	97 ± 19	84 ± 16
(mg/dL)	(65-175)	(61-112)	0.0001
Fasting insulin (μIU/mL)	10.8 (8.1 17.5)	6.5 (4.3-10.0)	< 0.0001
HbA1c (%)	5.69 ± 0.31	5.13 ± 0.40
	(4.70-6.60)	(4.00-6.10)	0.0005
HOMA index	2.5 (1.8-4.0)	1.4 (1.0-2.4)	< 0.0001

Data are reported as mean ± SD (range) or median (interquartile range).